Key result
Substrate ablation via dechanneling in patients ≥70 carries similar 30-day mortality to younger patients.
Why the study?
Although substrate ablation using the dechanneling technique is effective and safe for ventricular tachycardia, its application in elderly patients had not been specifically evaluated.
Is substrate-based ablation using the dechanneling technique safe and effective for preventing ventricular tachycardia recurrence in elderly patients (≥70 years)?
Cohort (n=108)
Is substrate-based ablation using the dechanneling technique safe and effective for preventing ventricular tachycardia recurrence in elderly patients (≥70 years)?
Substrate-based VT ablation using the dechanneling technique is safe and yields favorable long-term arrhythmic outcomes in elderly patients, with early mortality rates comparable to younger patients.
Supports VT ablation feasibility in octogenarians without excess risk; leaves open need for randomized outcome trials.
Introduction Ventricular tachycardia (VT) ablation through substrate elimination during sinus rhythm has been shown to be both effective and safe. The dechanneling technique, based on the isolation of slow-conduction channels, reduces the need for repeated VT induction and minimizes ablation volume. However, its application in elderly patients has not been specifically evaluated. Methods A total of 108 consecutive patients who underwent 112 substrate ablation procedures were included. All of the ablation procedures were done using scar dechanneling during sinus rhythm, without baseline VT induction. The primary procedural goal was the elimination of conducting-channel electrograms, followed by ablation of any residually inducible VT. A prospective analysis was conducted on the subgroup of patients aged ≥70 years. Clinical variables, procedural data, and long-term safety and arrhythmic outcomes were analysed. Results 54 patients aged ≥70 years (mean age 75 ± 4 years, 94% male) were included; 87% had ischemic cardiomyopathy, with a mean left ventricle ejection fraction (LVEF) of 34 ± 12%. The main clinical characteristics are summarized in the Table. The most common indication for ablation procedure was electrical storm (43%). Non-inducibility of any VT was achieved in 69% of cases. No procedure-related complications occurred. Thirty-day mortality did not differ significantly from younger patients (3.2% vs 1.7%, p=0.6). After long-term follow-up (7.8±3.1 years), VT recurrence occurred in 27% of patients. Total mortality was 39%, predominantly due to non-cardiovascular causes. Conclusions Substrate-based ablation using the dechanneling technique in elderly patients is safe and is associated with low early mortality and favourable long-term arrhythmic outcomes. Table. Baseline characteristics of older patients (≥ 70 years) undergoing scar dechanneling ablation. Quantitative variables are presented as mean ± standard deviation, whereas qualitative variables are presented as counts and percentages.
No takes yet. Share an insight, caveat, or question.
Mendez et al. (2026) conducted a cohort in Ventricular tachycardia (n=108). Substrate ablation by dechanneling technique vs. Younger patients (<70 years) was evaluated on 30-day mortality (p=0.6). Substrate ablation using the dechanneling technique in patients aged ≥70 years was associated with a 30-day mortality of 3.2%, not significantly different from younger patients (1.7%, p=0.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: